Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro

Eng-Guan Chua1, Phebe Verbrugghe1, Timothy T Perkins1

  • 1The Marshall Centre for Infectious Diseases Research and Training, School of Pathology and Laboratory Medicine (M502), The University of Western Australia, 35 Stirling Highway, Nedlands, WA 6009, Australia.

Insights

Fucoidans, derived from marine algae, did not inhibit Helicobacter pylori growth but reduced its adhesion to stomach cells in vitro. Further research is suggested for their clinical use.

Area of Science:

  • Marine natural products
  • Microbiology
  • Cell biology

Background:

  • Fucoidans are complex sulfated polysaccharides from marine algae.
  • Helicobacter pylori is a significant gastric pathogen requiring antibiotic treatment.
  • Investigating natural compounds for anti-H. pylori activity is crucial.

Purpose of the Study:

  • To evaluate the in vitro efficacy of fucoidans against Helicobacter pylori.
  • To determine if fucoidans inhibit H. pylori growth and adhesion to gastric cells.
  • To assess the safety of fucoidans on gastric epithelial cells.

Main Methods:

  • Three fucoidan extracts (Fucus A, Fucus B, Undaria) were tested.
  • Bacterial growth inhibition assays were performed.
  • Adhesion assays using gastric epithelial cells (AGS) were conducted.
  • Cytotoxicity of fucoidans on AGS cells was evaluated.

Main Results:

  • Fucoidans did not inhibit H. pylori growth in culture media.
  • High concentration (1000 µg/mL) fucoidans were toxic to AGS cells.
  • Lower concentration (100 µg/mL) fucoidans significantly reduced H. pylori adhesion to AGS cells.

Conclusions:

  • Fucoidans show potential in reducing H. pylori adhesion to gastric cells.
  • Fucoidans may serve as complementary agents in H. pylori management.
  • Further in vitro and in vivo studies are warranted to explore clinical applications.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.1K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
30
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.2K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
878